Horizon Investments’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.2M Buy
174,294
+13,311
+8% +$617K 0.09% 196
2026
Q1
$6.95M Buy
160,983
+37,137
+30% +$1.69M 0.08% 225
2025
Q4
$5.49M Sell
123,846
-29,658
-19% -$1.28M 0.07% 234
2025
Q3
$6.38M Buy
153,504
+50,504
+49% +$2.04M 0.08% 198
2025
Q2
$3.71M Buy
+103,000
New +$3.82M 0.06% 245
2025
Q1
– Sell
-47
Closed -$1.75K – 912
2024
Q4
$1.75K Hold
47
– – ﹤0.01% 740
2024
Q3
$1.88K Buy
47
+32
+213% +$1.21K ﹤0.01% 711
2024
Q2
$505 Sell
15
-27
-64% -$850 ﹤0.01% 797
2024
Q1
$1.3K Buy
42
+27
+180% +$821 ﹤0.01% 714
2023
Q4
$449 Hold
15
– – ﹤0.01% 746
2023
Q3
$487 Hold
15
– – ﹤0.01% 718
2023
Q2
$451 Hold
15
– – ﹤0.01% 691
2023
Q1
$401 Buy
+15
New +$417 ﹤0.01% 700
2021
Q1
– Sell
-30,416
Closed -$1.1M – 436
2020
Q4
$1.1M Buy
+30,416
New +$1.03M 1.26% 25
2018
Q4
– Sell
-22,171
Closed -$727K – 278
2018
Q3
$727K Hold
22,171
– – 0.02% 173
2018
Q2
$687K Buy
+22,171
New +$634K 0.03% 176

Other funds holding OHI

Horizon Investments's OHI Position: Q2 2026 in Review

Horizon Investments increased its Omega Healthcare (OHI) stake by 8.3% in Q2 2026, buying an estimated $617K and bringing the position to 174,294 shares worth $8.2M. The position accounts for 0.09% of the portfolio, ranked #196.

Horizon Investments first reported a position in OHI in Q2 2018 and has held it in 16 quarters since. 764 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Horizon Investments held 174,294 shares of Omega Healthcare worth $8.2M as of Q2 2026.
  • Horizon Investments bought 13,311 Omega Healthcare shares in Q2 2026, an estimated $617K.
  • Omega Healthcare made up 0.09% of Horizon Investments's portfolio in Q2 2026, its #196 holding.
  • Horizon Investments first reported a position in Omega Healthcare in Q2 2018 and has held it in 16 quarters since.
  • 764 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.